IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels

Molecular Vision

Volumn 21, Issue , 2015, Pages 604-611

  Zhang, Qiuhua ^a   Jiang, Youde ^b   Steinle, Jena J ^a,b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACETYLCYSTEINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTEIN KINASE C ZETA; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN; GLUCOSE; IGFBP3 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; PROTEIN KINASE C; RECOMBINANT PROTEIN; SOMATOMEDIN C; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOPRECIPITATION; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; METABOLISM; PHOSPHORYLATION; RETINA BLOOD VESSEL;

CELLS, CULTURED; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN KINASE C; RECOMBINANT PROTEINS; RETINAL VESSELS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930209893     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005; 438:960-6. [PMID: 16355161].
2. Aiello LP. The potential role of PKC beta in diabetic retinop­athy and macular edema. Surv Ophthalmol 2002; 47:Suppl 2S263-9. [PMID: 12507628].
3. Agrawal NK, Kant S. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes. 2014; 5:697-710. [PMID: 25317247].
4. Rangasamy S, McGuire PG, Franco Nitta C, Monickaraj F, Oruganti SR, Das A. Chemokine mediated monocyte traf­ficking into the retina: Role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. PLoS ONE 2014; 9:e108508. [PMID: 25329075].
5. Elahy M, Baindur-Hudson S, Cruzat VF, Newsholme P, Dass CR. Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy. J Endocrinol 2014; 222:R129-39. [PMID: 24928938].
6. Park HY, Kim JH, Park CK. Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model. Am J Pathol 2014; 184:1752-62. [PMID: 24709590].
7. Bazzaz JT, Amoli MM, Pravica V, Chandrasecaran R, Boulton AJ, Larijani B, Hutchinson IV. eNOS gene polymorphism association with retinopathy in type 1 diabetes. Ophthalmic Genet 2010; 31:103-7. [PMID: 20565248].
8. Titchenell PM, Lin CM, Keil JM, Sundstrom JM, Smith CD, Antonetti DA. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction. Biochem J 2012; 446:455-67. [PMID: 22721706].
9. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: Evidence for in vivo biological activity. J Clin Endocrinol Metab 2000; 85:1518-24. [PMID: 10770191].
10. Zhang Q, Guy K, Pagadala J, Jiang Y, Walker RJ, Liu L, Soder­land C, Kern TS, Ferry R, He H, Yates CR, Miller DD, Steinle JJ. Compound 49b Prevents Diabetes-Induced Apop­tosis through Increased IGFBP-3 Levels. Invest Ophthalmol Vis Sci 2012; 53:3004-13. [PMID: 22467575].
11. Kushlinskii NE, Gershtein ES, Nikolaev AA, Delektorskaya VV, Korotkova EA, Dvorova EK, Kostyleva OI. Insulin-like growth factors (IGF), IGF-binding proteins (IGFBP), and vascular endothelial growth factor (VEGF) in blood serum of patients with colorectal cancer. Bull Exp Biol Med 2014; 156:684-8. [PMID: 24770758].
12. Jarajapu YP, Cai J, Yan Y, Li Calzi S, Kielczewski JL, Hu P, Shaw LC, Firth SM, Chan-Ling T, Boulton ME, Baxter RC, Grant MB. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS ONE 2012; 7:e39398. [PMID: 22792172].
13. Kim SR, Lee KS, Lee KB, Lee YC. Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma. Allergy 2012; 67:869-77. [PMID: 22563687].
14. Baxter RC. IGF binding proteins in cancer: Mechanistic and clinical insights. Nat Rev Cancer 2014; 14:329-41. [PMID: 24722429].
15. Nguyen DV, Li Calzi S, Shaw LC, Kielczewski JL, Korah HE, Grant MB. An ocular view of the IGF-IGFBP system. Growth Horm IGF Res 2013; 23:45-52. [PMID: 23578754].
16. Kim HS. Role of insulin-like growth factor binding protein-3 in glucose and lipid metabolism. Ann Pediatr Endocrinol Metab. 2013; 18:9-12. [PMID: 24904844].
17. Zhang Q, Jiang Y, Miller MJ, Peng B, Liu L, Soderland C, Tang J, Kern TS, Pintar J, Steinle JJ. IGFBP-3 and TNF-alpha Regulate Retinal Endothelial Cell Apoptosis. Invest Ophthalmol Vis Sci 2013; 54:5376-84. [PMID: 23868984].
18. Zhang Q, Soderland D, Steinle JJ. TNFalpha inhibits IGFBP-3 through activation of p38alpha and casein kinase 2 in human retinal endothelial cells. PLoS ONE 2014; 9:e103578. [PMID: 25073020].
19. Zhang Q, Steinle JJ. IGFBP-3 inhibits TNF-alpha production and TNFR-2 signaling to protect against Retinal Endothelial Cell Apoptosis. Microvasc Res 2014; 95:76-81. [PMID: 25086184].
20. Kielczewski JL, Li Calzi S, Shaw LC, Cai J, Qi X, Ruan Q, Wu L, Liu L, Hu P, Chan-Ling T, Mames RN, Firth S, Baxter RC, Turowski P, Busik JV, Boulton ME, Grant MB. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Invest Ophthalmol Vis Sci 2011; 52:8278-86. [PMID: 21931131].
21. Rajwani A, Ezzat V, Smith J, Yuldasheva NY, Duncan ER, Gage M, Cubbon RM, Kahn MB, Imrie H, Abbas A, Viswambharan H, Aziz A, Sukumar P, Vidal-Puig A, Sethi JK, Xuan S, Shah AM, Grant PJ, Porter KE, Kearney MT, Wheatcroft SB. Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide produc­tion, lowers blood pressure, and protects against atheroscle­rosis. Diabetes 2012; 61:915-24. [PMID: 22357965].
22. Edgar K, Gardiner TA, van Haperen R, de Crom R, McDonald DM. Enos over expression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage. Invest Ophthalmol Vis Sci 2012; 53:6833-50. [PMID: 22930723].
23. She H, Nakazawa T, Matsubara A, Hisatomi T, Young TA, Michaud N, Connolly E, Hafezi-Moghadam A, Gragoudas ES, Miller JW. Reduced photoreceptor damage after photo­dynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2007; 48:2268-77. [PMID: 17460290].
24. Takahashi T, Harris RC. Role of endothelial nitric oxide synthase in diabetic nephropathy: Lessons from diabetic eNOS knockout mice. J Diabetes Res. 2014; 30:590541
25. Gangadharan Komala M, Gross S, Mudaliar H, Huang C, Pegg K, Mather A, Shen S, Pollock CA, Panchapakesan U. Inhibi­tion of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice. PLoS ONE 2014; 9:e108994. [PMID: 25369239].
26. Lei S, Li H, Xu J, Liu Y, Gao X, Wang J, Ng KF, Lau WB, Ma XL, Rodrigues B, Irwin MG, Xia Z. Hyperglycemia-induced protein kinase C beta2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expres­sion and Akt/eNOS signaling. Diabetes 2013; 62:2318-28. [PMID: 23474486].
27. Omri S, Behar-Cohen F, Rothschild PR, Gelize E, Jonet L, Jeanny JC, Omri B, Crisanti P. PKCzeta mediates breakdown of outer blood-retinal barriers in diabetic retinopathy. PLoS ONE 2013; 8:e81600. [PMID: 24312324].
28. Kaplan JS, Mohr C, Rossi DJ. Opposite actions of alcohol on tonic GABA(A) receptor currents mediated by nNOS and PKC activity. Nat Neurosci 2013; 16:1783-93. [PMID: 24162656].
29. Huang Q, Yuan Y. Interaction of PKC and NOS in signal trans­duction of microvascular hyperpermeability. Am J Physiol 1997; 273:H2442-51. [PMID: 9374783].
30. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 2010; 59:2872-82. [PMID: 20693346].
31. Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo LM, Jonet L, Savoldelli M, Omri B, Crisanti P. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: Role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol 2011; 179:942-53. [PMID: 21712024].
32. Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 2004; 279:53232-40. [PMID: 15485880].
33. Kielczewski JL, Hu P, Shaw LC, Li Calzi S, Mames RN, Gardiner TA, McFarland E, Chan-Ling T, Grant MB. Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol 2011; 178:1517-28. [PMID: 21435441].
34. Liu M, Xiang G, Lu J, Xiang L, Dong J, Mei W. TRAIL protects against endothelium injury in diabetes via Akt-eNOS signaling. Atherosclerosis 2014; 237:718-24. [PMID: 25463111].
35. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986; 250:H815-21. [PMID: 3085520].
36. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-6. [PMID: 3007998].
37. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y. Protein kinase C zeta subspecies from rat brain: Its structure, expression, and properties. Proc Natl Acad Sci USA 1989; 86:3099-103. [PMID: 2470089].
38. Jiang Y, Zhang Q, Steinle JJ. Intravitreal Injection of IGFBP-3 Restores Normal Insulin Signaling in Diabetic Rat Retina. PLoS ONE 2014; 9:e93788. [PMID: 24695399].
39. Zhang Q, Jiang Y, Toutounchian JJ, Soderland C, Yates CR, Steinle JJ. Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions. Mol Vis 2013; 19:796-803. [PMID: 23592916].